Original Query: ALL
Previous Study | Return to List | Next Study

Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ (CTTNKTL-Ⅲ/Ⅳ)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01501149
Recruitment Status : Recruiting
First Posted : December 29, 2011
Last Update Posted : July 17, 2015
Second Hospital of Shanxi Medical University
Shanxi Province Cancer Hospital
Wuhan University
Wuhan TongJi Hospital
Wuhan Union Hospital, China
Qingdao University
Cancer Hospital of Guizhou Province
Xinyang Central Hospital
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Information provided by (Responsible Party):
Mingzhi Zhang, Zhengzhou University